VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $382,358 | $132,360 | $427,640 | $397,006 |
| - Cash | $221,416 | $102,707 | $40,172 | $19,813 |
| + Debt | $10,462 | $292 | $116 | $19,985 |
| Enterprise Value | $171,404 | $29,945 | $387,584 | $397,178 |
| Revenue | $27,341 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $27,341 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$79,848 | -$86,413 | -$57,554 | -$23,264 |
| % Margin | -292% | – | – | – |
| Net Income | -$93,735 | -$87,009 | -$60,497 | -$23,531 |
| % Margin | -342.8% | – | – | – |
| EPS Diluted | -2.12 | -3.23 | -2.4 | -1.01 |
| % Growth | 34.4% | -34.6% | -137.6% | – |
| Operating Cash Flow | -$56,259 | -$72,139 | -$38,212 | -$14,897 |
| Capital Expenditures | -$74 | -$57 | -$93 | -$56 |
| Free Cash Flow | -$56,333 | -$72,196 | -$38,305 | -$14,953 |